A case of acneiform skin eruption associated with ZD1839(Iressa®)

Yong Ju Kim, Kyu Chul Hwang, Dong Soo Yu, Chil Hwan Oh, Hae Jun Song

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)


    Epidermal growth factor (EGF) has an important role in the regulation of the proliferation and differentiation of epidermal keratinocytes, as well as in the survival, angiogenesis and metastasis of various cancer cells. There have been some reports of acneiform skin lesions that occurred in the cancer patients treated with ZD1839(Iressa®), an inhibitor of EGF tyrosine kinase. We report a case of acneiform eruption related to the anticancer drug, ZD1839(Iressa®).

    Original languageEnglish
    Pages (from-to)478-481
    Number of pages4
    JournalKorean Journal of Dermatology
    Issue number4
    Publication statusPublished - 2004 Apr


    • Acneiform eruption
    • ZD1839

    ASJC Scopus subject areas

    • Dermatology


    Dive into the research topics of 'A case of acneiform skin eruption associated with ZD1839(Iressa®)'. Together they form a unique fingerprint.

    Cite this